News Image

Cabaletta Bio to Participate in Guggenheim’s SMID Cap Biotech Conference

Provided By GlobeNewswire

Last update: Jan 29, 2025

PHILADELPHIA, Jan. 29, 2025 (GLOBE NEWSWIRE) -- Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage biotechnology company focused on developing and launching the first curative targeted cell therapies designed specifically for patients with autoimmune diseases, today announced that the Company will participate in a fireside chat at Guggenheim’s SMID Cap Biotech Conference on Wednesday, February 5, 2025, at 10:30 a.m. ET in New York, NY.

Read more at globenewswire.com

CABALETTA BIO INC

NASDAQ:CABA (5/30/2025, 8:00:01 PM)

After market: 1.8699 0 (-0.01%)

1.87

-0.04 (-2.09%)



Find more stocks in the Stock Screener

CABA Latest News and Analysis

ChartMill News Image16 days ago - ChartmillTop movers in Friday's pre-market session

Discover the top movers in Friday's pre-market session and stay informed about market dynamics.

Mentions: GTI GLOB EVLV AYTU ...

ChartMill News Image17 days ago - ChartmillThese stocks are gapping in today's session

Traders are paying attention to the gapping stocks in Thursday's session. Let's dive into which stocks are experiencing notable gaps.

Mentions: BOOT GTI FL TE ...

Follow ChartMill for more